Skip to content
TriangleGet started
← Breast Cancer

FOR PATIENTS · SOURCE READING

Neoadjuvant therapy for breast cancer

Source: Hormone Therapy for Breast Cancer, National Cancer Institute.

Source updated: December 2, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

NCI patient treatment article for this disease Exact source article; not a clinically reviewed indication or current-standard recommendation.

Context: Hormone Therapy for Breast Cancer / How is hormone therapy used to treat breast cancer?

Postmenopausal women with HR-positive breast cancer who cannot take chemotherapy or who cannot have surgery right away may receive hormone therapy with aromatase inhibitors before surgery (neoadjuvant therapy).

Clinical trials are studying the effectiveness of neoadjuvant hormone therapy for premenopausal women with HR-positive tumors.

Preserved source evidence · Independent clinical review pending · Not medical advice